story of the week
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous SCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
N. Engl. J. Med 2022 Sep 12;[EPub Ahead of Print], ND Gross, DM Miller, NI Khushalani, V Divi, ES Ruiz, EJ Lipson, F Meier, YB Su, PL Swiecicki, J Atlas, JL Geiger, A Hauschild, JH Choe, BGM Hughes, D Schadendorf, VA Patel, J Homsi, JM Taube, AM Lim, R Ferrarotto, HL Kaufman, F Seebach, I Lowy, SY Yoo, M Mathias, K Fenech, H Han, MG Fury, D RischinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.